Brought to you by 
Barr offers to buy European generics company Pliva for $2.2bn
13 Oct 2006
Executive Summary
Hoping to capitalize on the central and eastern European pharmaceutical markets, generic and brand drug maker Barr Pharmaceuticals will make a tender offer of $2.2bn in cash to acquire Croatian generic company Pliva DD. Pliva's supervisory board has endorsed the proposed acquisition.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
-
Drug Delivery
- Topical Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Barr offers to buy European generics company Pliva for $2.2bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice